Research shows that in patients presenting to the emergency department with acute dyspnea, increased calprotectin was ...

Low income was linked to higher pulmonary risk and poorer health among long-term survivors of blood or marrow transplants.

Across four prospective U.S. cohorts, 4.5% of those 18-49 years old met criteria for COPD, defined as spirometric airflow ...

Report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Sarepta Therapeutics at 1-888-SAREPTA ...

Three critically ill patients treated with procizumab experience a full reversal of cardiogenic shock in 48 hours.

If a newborn baby fails to breathe properly, parents are in great anxiety. In this case, it is likely to be a symptom of 'newborn dyspnea syndrome', a disease that occurs mainly in premature infants ...

Patritumab deruxtecan shows promising survival rates and manageable safety in treating leptomeningeal metastatic disease, ...

A recent study found that a team-based palliative care model, involving registered nurses (RNs) and nursing technicians (NTs) providing home care, is an ...

The German and Dutch intelligence services said Friday that Russia is increasing its use of chemical weapons in Ukraine. Moscow's military is employing "a wide range of chemical weapons with ...

Apraxia Market Epidemiology Report 2025-2035: Pipeline Therapies, Drugs Sales, and Regional Outlook The report provides a detailed analysis of the current apraxia marketed drugs and late-stage ...

A broad spectrum of systemic inflammatory manifestations defines VEXAS syndrome, with cutaneous, respiratory, and vascular involvement commonly reported.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: ...